UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 232

Sortiert nach

Infection of Human Airway Epithelium by Human and Avian Strains of Influenza A Virus

Journal of Virology, 2006-08, Vol.80 (16), p.8060-8068

2006

Link zum Volltext

Verfügbarkeit prüfen

Cross-Reactivity to Highly Pathogenic Avian Influenza H5N1 Viruses after Vaccination with Nonadjuvanted and MF59-Adjuvanted Influenza A/Duck/Singapore/97 (H5N3) Vaccine: A Potential Priming Strategy

The Journal of infectious diseases, 2005-04, Vol.191 (8), p.1210-1215

2005

Link zum Volltext

Verfügbarkeit prüfen

Reproducibility of serologic assays for influenza virus A (H5N1)

Emerging infectious diseases, 2009-08, Vol.15 (8), p.1252-1259

2009

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology and pathogenesis of influenza

Journal of antimicrobial chemotherapy, 1999-11, Vol.44 Suppl B (suppl_2), p.3-9

Zambon, M C

1999

Link zum Volltext

Verfügbarkeit prüfen

Antigenically Distinct MF59-Adjuvanted Vaccine to Boost Immunity to H5N1

The New England journal of medicine, 2008-10, Vol.359 (15), p.1631-1633

2008

Link zum Volltext

Verfügbarkeit prüfen

Confronting the avian influenza threat: vaccine development for a potential pandemic

The Lancet infectious diseases, 2004-08, Vol.4 (8), p.499-509

2004

Link zum Volltext

Verfügbarkeit prüfen

The pathogenesis of influenza in humans

Reviews in medical virology, 2001-07, Vol.11 (4), p.227-241

Zambon, Maria C.

2001

Link zum Volltext

Verfügbarkeit prüfen

Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes

Emerging infectious diseases, 2005-03, Vol.11 (3), p.411-416

2005

Link zum Volltext

Verfügbarkeit prüfen

Influenza vaccine: going through a sticky patch

The Lancet (British edition), 2017-08, Vol.390 (10095), p.627-628

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase I Evaluation of Intranasal Trivalent Inactivated Influenza Vaccine with Nontoxigenic Escherichia coli Enterotoxin and Novel Biovector as Mucosal Adjuvants, Using Adult Volunteers

Journal of Virology, 2006-05, Vol.80 (10), p.4962-4970

2006

Link zum Volltext

Verfügbarkeit prüfen

Molecular diagnosis of influenza

Reviews in medical virology, 2002-11, Vol.12 (6), p.375-389

2002

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial

The Lancet (British edition), 2006-05, Vol.367 (9523), p.1657-1664

2006

Link zum Volltext

Verfügbarkeit prüfen

Patterns of systemic and local inflammation in patients with asthma hospitalised with influenza

The European respiratory journal, 2019-10, Vol.54 (4), p.1900949

2019

Link zum Volltext

Verfügbarkeit prüfen

Design and Validation of an H5 TaqMan Real-Time One-Step Reverse Transcription-PCR and Confirmatory Assays for Diagnosis and Verification of Influenza A Virus H5 Infections in Humans

Journal of Clinical Microbiology, 2007-05, Vol.45 (5), p.1535-1543

2007

Link zum Volltext

Verfügbarkeit prüfen

Fatal cases of influenza a in childhood

PloS one, 2009-10, Vol.4 (10), p.e7671-e7671

2009

Link zum Volltext

Verfügbarkeit prüfen

Reproducibility of serology assays for pandemic influenza H1N1: Collaborative study to evaluate a candidate WHO International Standard

Vaccine, 2012-01, Vol.30 (2), p.210-217

2012

Link zum Volltext

Verfügbarkeit prüfen

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza

The Lancet (British edition), 2001-06, Vol.357 (9272), p.1937-1943

2001

Link zum Volltext

Verfügbarkeit prüfen

Combined PCR-Heteroduplex Mobility Assay for Detection and Differentiation of Influenza A Viruses from Different Animal Species

Journal of Clinical Microbiology, 2001-11, Vol.39 (11), p.4097-4102

2001

Link zum Volltext

Verfügbarkeit prüfen

The UK’s multidisciplinary response to an Ebola epidemic

Clinical medicine (London, England), 2017-08, Vol.17 (4), p.332-337

2017

Link zum Volltext

Verfügbarkeit prüfen

Influenza AH1N2 viruses, United Kingdom, 2001-02 influenza season

Emerging infectious diseases, 2003-03, Vol.9 (3), p.304-310

2003

Link zum Volltext

Verfügbarkeit prüfen

Oseltamivir-resistant pandemic (H1N1) 2009 virus infection in England and Scotland, 2009-2010

Emerging infectious diseases, 2011-10, Vol.17 (10), p.1807-1815

2011

Link zum Volltext

Verfügbarkeit prüfen

Surveillance for antiviral resistance

Influenza and other respiratory viruses, 2013-01, Vol.7 (s1), p.37-43

Zambon, Maria C.

2013

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children

Vaccine, 2008-11, Vol.26 (50), p.6383-6391

2008

Link zum Volltext

Verfügbarkeit prüfen

Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies

Antiviral therapy, 2008-01, Vol.13 (6), p.809-820

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults

Vaccine, 2008-08, Vol.26 (33), p.4160-4167

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 232

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(227)
Mit Volltextzugriff
(218)

Publikationsform

Artikel
(231)
Reviews
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Infection of Human Airway Epithelium by Human and Avian Strains of Influenza A Virus

Cross-Reactivity to Highly Pathogenic Avian Influenza H5N1 Viruses after Vaccination with Nonadjuvanted and MF59-Adjuvanted Influenza A/Duck/Singapore/97 (H5N3) Vaccine: A Potential Priming Strategy

Reproducibility of serologic assays for influenza virus A (H5N1)

Epidemiology and pathogenesis of influenza

Antigenically Distinct MF59-Adjuvanted Vaccine to Boost Immunity to H5N1

Confronting the avian influenza threat: vaccine development for a potential pandemic

The pathogenesis of influenza in humans

Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes

Influenza vaccine: going through a sticky patch

Phase I Evaluation of Intranasal Trivalent Inactivated Influenza Vaccine with Nontoxigenic Escherichia coli Enterotoxin and Novel Biovector as Mucosal Adjuvants, Using Adult Volunteers

Molecular diagnosis of influenza

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial

Patterns of systemic and local inflammation in patients with asthma hospitalised with influenza

Design and Validation of an H5 TaqMan Real-Time One-Step Reverse Transcription-PCR and Confirmatory Assays for Diagnosis and Verification of Influenza A Virus H5 Infections in Humans

Fatal cases of influenza a in childhood

Reproducibility of serology assays for pandemic influenza H1N1: Collaborative study to evaluate a candidate WHO International Standard

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza

Combined PCR-Heteroduplex Mobility Assay for Detection and Differentiation of Influenza A Viruses from Different Animal Species

The UK’s multidisciplinary response to an Ebola epidemic

Influenza AH1N2 viruses, United Kingdom, 2001-02 influenza season

Oseltamivir-resistant pandemic (H1N1) 2009 virus infection in England and Scotland, 2009-2010

Surveillance for antiviral resistance

Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children

Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies

Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults

Suchergebnisse filtern